Characteristics of gastrointestinal hemorrhage associated with pancreatic cancer: A retrospective review of 246 cases

By      

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 902-908

Science Publishers

Access to resources Recommend Favorite

A Phase I Study of Paclitaxel, Doxorubicin, and Cisplatin in Patients with Previously Untreated Epithelial Ovarian Cancer

By Naumann R.W.   Alvarez R.D.   Omura G.A.   Segars E.   Kilgore L.C.   Partridge E.E.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 450-453

Elsevier

Access to resources Recommend Favorite

Correlation between Extreme Drug Resistance Assay and Response to Primary Paclitaxel and Cisplatin in Patients with Epithelial Ovarian Cancer

By Eltabbakh G.H.   Piver M.S.   Hempling R.E.   Recio F.O.   Lele S.B.   Marchetti D.L.   Baker T.R.   Blumenson L.E.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients

By Romanini A.   Tanganelli L.   Carnino F.   Fanucchi A.   Lionetto R.   Pastorino S.   Cosio S.   Gadducci A.   Conte P.F.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 354-359

Elsevier

Access to resources Recommend Favorite

Intraperitoneal Cisplatin and Intravenous Paclitaxel in the Treatment of Epithelial Ovarian Cancer Patients with a Positive Second Look

By Makhija S.   Sabbatini P.   Aghajanian C.   Venkatraman E.   Spriggs D.R.   Barakat R.  

Gynecologic Oncology, Vol. 79, Iss. 1, 2000-10 ,pp. : 28-32

Elsevier

Access to resources Recommend Favorite